In other words, rectal cancer with KRAS mutation had higher intrinsic heterogeneity than KRAS wild-type cancers did; this intrinsic heterogeneity in KARS mutation should be addressed more in detail by further research. The gene discussed is KRAS; the disease is rectal cancer.